The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and clinical applications without systematic review methodology
PubMed 28302011 · doi:10.2174/0929867324666170316115938
What was done
This narrative review summarizes recent in vitro studies and clinical trials examining the pharmacological mechanisms, therapeutic activities, and adverse effect profile of hydroxychloroquine (HCQ) in rheumatic conditions (such as systemic lupus erythematosus and rheumatoid arthritis) and other potential disease areas.
What was found
The abstract reports no quantitative data or numerical findings. It qualitatively notes that hydroxychloroquine possesses immunomodulatory, anti-inflammatory, anti-platelet, metabolic, and antineoplastic activities, suggesting potential utility in conditions including systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, skin disease, and cancer.
Why it matters
The paper synthesizes the broad pharmacological and therapeutic actions of hydroxychloroquine across rheumatic and related pathologies.
Limits
As a narrative review, it lacks a systematic search protocol, formal study quality assessment, and quantitative synthesis. The abstract provides no specific study designs, participant numbers, effect estimates, or detailed safety data.
Cited by
- supports Chloroquine and hydroxychloroquine are antimalarial agents that are used to treat rheumatoid arthritis due to their anti-inflammatory properties.